Scholars Central

Short communicationPublished 6 Jun 2022

Developmental Treatment Progress for Atopic Dermatitis

Authors: Zhou Paul

Journal of Dermatitis

Volume 7 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Atopic Dermatitis (AD) is a chronic skin illness caused by complicated interactions between skin barrier abnormalities and a deregulated immune system, which is characterized by the activation of diverse T cell subsets at various phases of the disease. Until recently, the majority of patients were treated with moisturizers, topical steroids and topical calcineurin inhibitors, with systemic immunosuppressant are being recommended in seriously sick patients. New treatment techniques have been conceived and developed in recent years to target the many phases in the chain of molecular processes that rise to the AD phenotype. The focus of this short communication will be on current advancements in the treatment of Alzheimer's disease.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Dermatitis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Dermatitis
  • SubjectDermatology
  • BylineArticles whose byline prints “Zhou Paul”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels